Cargando…
Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313821/ https://www.ncbi.nlm.nih.gov/pubmed/35285080 http://dx.doi.org/10.1111/dme.14827 |
| _version_ | 1784754168025579520 |
|---|---|
| author | Ryder, Robert E. J. Yadagiri, Mahi Burbridge, Wyn Irwin, Susan P. Gandhi, Hardeep Bashir, Tahira Allden, Rachael A. Wyres, Melanie Cull, Melissa Bleasdale, John P. Fogden, Edward N. Anderson, Mark R. Sen Gupta, Piya |
| author_facet | Ryder, Robert E. J. Yadagiri, Mahi Burbridge, Wyn Irwin, Susan P. Gandhi, Hardeep Bashir, Tahira Allden, Rachael A. Wyres, Melanie Cull, Melissa Bleasdale, John P. Fogden, Edward N. Anderson, Mark R. Sen Gupta, Piya |
| author_sort | Ryder, Robert E. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9313821 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93138212022-07-30 Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service Ryder, Robert E. J. Yadagiri, Mahi Burbridge, Wyn Irwin, Susan P. Gandhi, Hardeep Bashir, Tahira Allden, Rachael A. Wyres, Melanie Cull, Melissa Bleasdale, John P. Fogden, Edward N. Anderson, Mark R. Sen Gupta, Piya Diabet Med Letters John Wiley and Sons Inc. 2022-03-29 2022-07 /pmc/articles/PMC9313821/ /pubmed/35285080 http://dx.doi.org/10.1111/dme.14827 Text en © 2022 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters Ryder, Robert E. J. Yadagiri, Mahi Burbridge, Wyn Irwin, Susan P. Gandhi, Hardeep Bashir, Tahira Allden, Rachael A. Wyres, Melanie Cull, Melissa Bleasdale, John P. Fogden, Edward N. Anderson, Mark R. Sen Gupta, Piya Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title | Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title_full | Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title_fullStr | Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title_full_unstemmed | Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title_short | Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service |
| title_sort | duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the first national health service (nhs) endobarrier service |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313821/ https://www.ncbi.nlm.nih.gov/pubmed/35285080 http://dx.doi.org/10.1111/dme.14827 |
| work_keys_str_mv | AT ryderrobertej duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT yadagirimahi duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT burbridgewyn duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT irwinsusanp duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT gandhihardeep duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT bashirtahira duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT alldenrachaela duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT wyresmelanie duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT cullmelissa duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT bleasdalejohnp duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT fogdenedwardn duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT andersonmarkr duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice AT senguptapiya duodenaljejunalbypasslinerforthetreatmentoftype2diabetesandobesity3yearoutcomesinthefirstnationalhealthservicenhsendobarrierservice |